Moreover, we found that the serum level of VAPA, which was at a very low level in healthy serum, was significantly higher in HCC‐BM patients than that in HCC patients without bone‐metastasis (Figure 2H). This evidence concerns the gene VAPA and hepatocellular carcinoma.